VCP co-localizes with aggregated Ataxin-3 [30], TDP-43 [31] or with ubiquitinated inclusions in Alzheimer's and Parkinson's disease [32] suggesting that modulation of VCP activity might have a broad relevance for protein clearance (including neurodegenerative) disorders. This evidence concerns the gene VCP and Parkinson disease.